Abstract
We evaluated the occurrence of antiphospholipid antibodies (aPLs) in acute adult IgA vasculitis (IgAV), and potential correlations with IgAV clinical presentation. We determined lupus anticoagulants (LAs) and IgG, IgM, and IgA isotypes of anticardiolipin antibodies (aCL), antibodies against β2-glycoprotein I (aβ2GPI) and against the phosphatidylserine-prothrombin complex (aPS/PT) in prospectively collected, histologically proven IgAV, diagnosed for the first time between January 2013 and February 2018 at our secondary/tertiary rheumatology center. During the 62 months, we determined aPLs in 125 IgAV patients (56.8% male; median (IQR) age 64.7 (48.6–78.2) years). Sixty-four (51.2%) patients had aPLs. We found LAs, aPS/PT, aβ2GPI, and aCL in 24.8%, 21.6%, 13.6%, and 11.2% of cases, respectively. With 17.6%, the IgA aPS/PT was the most common aPL subtype. aPL-positive and aPL-negative patients did not differ in the clinical presentation of acute IgAV or in the frequency of thrombotic events. aPL-positive IgAV patients had significantly higher erythrocyte sedimentation rate (p < 0.001), and C-reactive protein (p < 0.001). The subset of IgA aPS/PT-positive patients more commonly had renal involvement in acute disease (RR 2.4 (95% CI 1.6–3.7)). aPLs are commonly detected during acute IgAV episodes. Patients with aPLs have similar clinical presentation, but higher markers of inflammation at than those without them. The subset of IgAV patients with IgA aPS/PT more commonly had renal involvement.
References
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11. https://doi.org/10.1002/art.37715
Hocevar A, Rotar Z, Ostrovrsnik J et al (2014) Incidence of IgA vasculitis in the adult Slovenian population. Br J Dermatol 171:524–527. https://doi.org/10.1111/bjd.12946
Hocevar A, Rotar Z, Jurcic V et al (2015) Patient age, gender and extent of purpura may suggest short-term outcomes in adults with IgA vasculitis. Rheumatology (Oxford) 54:1330–1332. https://doi.org/10.1093/rheumatology/kev122
Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch-Schonlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278
Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306. https://doi.org/10.1111/j.1538-7836.2006.01753.x
de Groot PG, Urbanus RT (2015) Antiphospholipid syndrome -- not a noninflammatory disease. Semin Thromb Hemost 41:607–614. https://doi.org/10.1055/s-0035-1556725
Lally L, Sammaritano LR (2015) Vasculitis in antiphospholipid syndrome. Rheum Dis Clin N Am 41:109–123. https://doi.org/10.1016/j.rdc.2014.09.009
Tomasson G, Monach PA, Merkel PA (2009) Thromboembolic disease in vasculitis. Curr Opin Rheumatol 21:41–46. https://doi.org/10.1097/BOR.0b013e32831de4e7
Kawakami T, Watabe H, Mizoguchi M, Soma Y (2006) Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schonlein purpura. Br J Dermatol 155:983–987. https://doi.org/10.1111/j.1365-2133.2006.07457.x
Kawakami T, Yamazaki M, Mizoguchi M, Soma Y (2008) High titer of serum antiphospholipid antibody levels in adult Henoch-Schonlein purpura and cutaneous leukocytoclastic angiitis. Arthritis Rheum 59:561–567. https://doi.org/10.1002/art.23528
Kimura S, Takeuchi S, Soma Y, Kawakami T (2013) Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schonlein purpura. Clin Exp Dermatol 38:730–736. https://doi.org/10.1111/ced.12089
Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, Jones R, Lanyon P, Muir A, Scott D, Young L, Luqmani RA (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68:1827–1832. https://doi.org/10.1136/ard.2008.101279
Božič B, Stegnar M, Kveder T et al (1997) Influence of degraded phosphatidylserine on binding of antiphospholipid antibodies. Int Arch Allergy Immunol 112:19–26. https://doi.org/10.1159/000237426
Čučnik S, Ambrožič A, Božič B et al (2000) Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin Chem Lab Med 38:777–783. https://doi.org/10.1515/CCLM.2000.111
Zigon P, Ambrozic A, Cucnik S et al (2011) Modified phosphatidylserine-dependent antiprothrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies. Clin Chem Lab Med 49:1573–1018. https://doi.org/10.1515/CCLM.2011.162
Petri M (2000) Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 15:145–151. https://doi.org/10.1006/jaut.2000.0409
Stassen PM, Derks RP, Kallenberg CG, Stegeman CA (2008) Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors. Rheumatology (Oxford) 47:530–534. https://doi.org/10.1093/rheumatology/ken035
Kimball AS, Obi AT, Diaz JA, Henke PK (2016) The emerging role of NETs in venous thrombosis and immunothrombosis. Front Immunol 7:236. https://doi.org/10.3389/fimmu.2016.00236
Rao AN, Kazzaz NM, Knight JS (2015) Do neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases? World J Cardiol 7:829–842. https://doi.org/10.4330/wjc.v7.i12.829
Funding
The study was funded by the Slovenian national research grant P3-0314.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Ethics approval and consent to participate
The informed consent for this study was not required nor obtained. The study was approved by the Slovenian National medical ethics committee.
Additional information
Rheumatology in Slovenia: Clinical practice and translational research
Rights and permissions
About this article
Cite this article
Hočevar, A., Rotar, Ž., Žigon, P. et al. Antiphospholipid antibodies in adult IgA vasculitis: observational study. Clin Rheumatol 38, 347–351 (2019). https://doi.org/10.1007/s10067-018-4248-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-018-4248-2